NEW YORK, March 1 (GenomeWeb News) - Pfizer has taken a global license to Jubilant Biosys' ChemBioBase gene family-specific small molecule inhibitor databases, Bangalore, India-based Jubilant said recently.
In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.
The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.
